NCT00110071
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +46 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,249 public trials
217 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT00002941
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +22 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
- University of South Alabama Medical Center Mobile, Alabama, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arizona Cancer Center Tucson, Arizona, United States
Completed
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
NCT00002618
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +11 more
- Locations
-
- Via Christi Regional Medical Center-Saint Francis Campus Wichita, Kansas, United States
- MBCCOP - LSU Medical Center New Orleans, Louisiana, United States
- Memorial Mission Hospital Asheville, North Carolina, United States
- Medical University of South Carolina Charleston, South Carolina, United States
NCT00217412
- Conditions
- Bone Marrow Diseases, Burkitt Lymphoma, Childhood Acute Promyelocytic Leukemia (M3), +61 more
- Locations
-
- Children's Oncology Group Philadelphia, Pennsylvania, United States
Completed
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma
NCT00054639
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +60 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00290472
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- Evanston Hospital CCOP Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
Completed
Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
NCT00058019
- Conditions
- Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +25 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT00121199
- Conditions
- Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- SWOG Portland, Oregon, United States
NCT00392496
- Conditions
- Adult Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada
Completed
PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT00303953
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States